Preclinical and clinical trials of the new tuberculosis drug perchlozon

Preclinical and clinical trials of the new tuberculosis drug perchlozon

The paper sets forth the stages of design and introduction of the new Russian tuberculosis (TB) drug perchlozon registered in the Russian Federation in 2012. Based on the results of Phases I-III clinical trials, the authors evaluate the efficacy and safety of the agent and consider the adverse effec...

Full description

Bibliographic Details
Main Authors: P K Yablonskiy, T I Vinogradova, Yu N Levashev, M V Pavlova, E K Zilber, A A Starshinova, N V Sapozhnikova, I V Chernokhaeva, L I Archakova, N V Zabolotnykh, M L Vitovskaya
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2016-03-01
Series:Терапевтический архив
Subjects:
tuberculosis
chemotherapy
perchlozon
preclinical evaluation
clinical efficacy
adverse events
indications for use
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/31957/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/31957/pdf

Similar Items